Robert Campbell, Ph.D. has been designated an Early Career Committee Vice-Chair for the ISTH and will serve two years before becoming the Chair of the Early Career Committee.
Discovery in Clinical Departments Chalk Talk Sponsored by University of Utah Molecular Medicine Program (U2M2) Presents “Protease activated receptor 4 (PAR4) functional genomics: characterization of platelet activation, desensitization and neutrophil interactions” By Paul Bray, M.D., Professor of Internal Medicine, Division of Hematology and Hematologic Malignancies and Molecular Medicine and Robert Campbell, Ph.D., Research Assistant Professor…
Entitled “Interleukin 6 receptor alpha expression in PMNs isolated from prematurely born neonates: decreased expression is associated with differential mTOR signaling,” this article explores the links between premature birth and dysregulated inflammation. The link to this article can be found here: https://www.nature.com/articles/s41390-019-0388-6
We are happy to report that Robert Campbell’s DOIM Academic Excellence Seed Grant Program application has been approved. Funding begins July l, 2019 through June 30, 2020.
Evolving evidence indicates that platelets and megakaryocytes (MKs) have unexpected activities in inflammation and infection; but whether viral infections upregulate biologically active, anti-viral immune genes in platelets and MKs is unknown. We examined anti-viral immune genes in these cells in dengue and influenza infections, viruses that are global public health threats. Using complementary biochemical, pharmacological,…
Project Title: Interferon-Induced Transmembrane Protein 3 (IFITM3) Regulates Thrombosis During Inflammation in Aging Project Period: 04/15/2019 – 03/31/2023
See the winning abstract and interview with Robert Campbell, PhD here by scrolling to the middle of the page.
Discovery in Clinical Departments Chalk Talk Sponsored by University of Utah Molecular Medicine Program (U2M2) Presents “The role of mTOR in regulating platelet hyperactivity in aging and sepsis” By Robert Campbell, PhD
Robert Campbell of Internal Medicine has been accepted into VPCAT (Vice President’s Clinical and Translational Research Scholars Program) See the announcement here.